A forum on synthetic biology: meet the great challenges with new technology

Weijie ZhaoNational 2020 · DOI

TL;DR

This forum brings together leading synthetic biologists to discuss the field's progress, current challenges, and future directions, particularly in light of the COVID-19 pandemic. Key takeaways highlight the rapid advancements in diagnostics, therapeutics, and vaccines driven by synthetic biology, alongside critical discussions on biosafety, ethics, and the need for global standards.

What Problem Does This Paper Address?

Synthetic biology, the engineering of biological systems, has rapidly evolved from a nascent field to a powerful tool for addressing global challenges. However, the field faces significant hurdles, including achieving predictable design, navigating complex biological systems, and ensuring responsible development and application. This paper addresses the need for a comprehensive discussion on the current state, future trajectory, and critical challenges of synthetic biology, especially in the context of its immediate impact on global health crises like COVID-19. It aims to bridge the gap between scientific innovation and public understanding, while also exploring the ethical and safety considerations inherent in manipulating life.

Methods

This paper is not a traditional research paper detailing specific experimental methods. Instead, it is a transcript of a panel discussion among eleven prominent synthetic biologists. The "method" here is a facilitated dialogue, where the chair poses questions and panelists share their expertise, insights, and perspectives on various aspects of synthetic biology. The discussion covers a broad range of topics, including:

  • Diagnostic Development: Utilizing CRISPR-based technologies, DNA barcoding, and cell-free systems for rapid and accurate COVID-19 detection.
  • Therapeutic Design: Engineering short RNAs, developing small molecules, and creating synthetic antibodies for disease treatment.
  • Vaccine Development: Exploring novel approaches like engineered BCG vaccines and self-replicating RNA platforms.
  • Environmental Sensing and Supply Chains: Leveraging synthetic biology for ecological monitoring and improving pharmaceutical supply chains.
  • Technological Advancements: Discussing the impact of AI, machine learning, and computational design.
  • Challenges: Identifying issues in predictable biodesign, understanding complex living systems, and ethical considerations.
  • Future Trends: Predicting breakthroughs in organoids, aging reversal, DNA data storage, and computational approaches.
  • Biosafety and Ethics: Addressing public misconceptions, the need for global standards, and technological solutions for safety.
  • International Organizations: Examining the role and challenges of global initiatives like GP-write, GBA, and EBRC.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Synthetic Biology as a Rapid Response Force: The COVID-19 pandemic starkly demonstrated synthetic biology's capacity for swift development of diagnostics, therapeutics, and vaccines, showcasing its critical role in global health security.
  • The Rise of Cell-Free Systems: Cell-free synthetic biology is emerging as a powerful platform for rapid prototyping, diagnostics, and portable manufacturing, offering significant advantages in speed and accessibility.
  • AI and Data-Driven Design are Transformative: The integration of artificial intelligence and big data analytics is revolutionizing synthetic biology by accelerating design cycles, improving predictability, and enabling deeper understanding of complex biological systems.
  • Predictable Biodesign Remains a Grand Challenge: Despite advancements, achieving robust and predictable design of living systems at the genetic level is still a major hurdle, requiring better integration of design, testing, and machine learning.
  • Global Collaboration and Standards are Crucial: Addressing the global nature of synthetic biology's impact necessitates international cooperation on ethical guidelines, biosafety regulations, and equitable access to technologies.
  • Public Perception and Communication are Key: Misconceptions about synthetic biology persist, highlighting the urgent need for clear, positive communication strategies to build public trust and support for responsible innovation.
  • Beyond Health: Broader Societal Impact: Synthetic biology holds immense potential for addressing challenges in aging, agriculture, and environmental sustainability, promising to improve quality of life and planetary health.

Key Results

  • COVID-19 Diagnostics: Development of rapid, home-based diagnostic kits (e.g., 15-minute tests, CRISPR-based kits) and wearable diagnostic technologies embedded in face masks.
  • COVID-19 Therapeutics: Progress in developing short RNAs to target viral replication, exploring small-molecule drugs, and screening synthetic antibody libraries.
  • COVID-19 Vaccines: Advancements in engineering BCG vaccines to express SARS-CoV-2 antigens and utilizing self-replicating RNA platforms.
  • DNA Data Storage: Demonstrated ability to store a terabyte of information in a minuscule amount of DNA, with potential for in vivo data storage.
  • International Organizations: The existence and ongoing work of initiatives like Global Biofoundries Alliance (GBA), GP-write, and Engineering Biology Research Consortium (EBRC) in promoting collaboration, standardization, and roadmap development.

Limitations and Future Work

Limitations:

  • Predictability in Design: The paper acknowledges that achieving predictable and robust design of living systems remains a significant challenge.
  • Understanding Complex Systems: Our knowledge of gene functions, interactions, and higher organisms is still limited, hindering the design of complex biological systems.
  • Global Ethical Standards: A lack of universally agreed-upon global standards for ethics in synthetic biology is a concern.
  • Public Misconceptions: Persistent public misconceptions about synthetic biology require ongoing efforts in communication and education.
  • Funding and Engagement for International Collaborations: Securing international funding and maintaining sustained engagement for collaborative projects are identified as difficulties for organizations like GBA.

Future Work:

  • Enhanced AI and Machine Learning: Continued development and application of AI and data-driven approaches for better design and understanding of biological systems.
  • Organoid Development and Aging Reversal: Further research into organoids for therapeutic development and exploring technologies for aging reversal.
  • In Vivo DNA Data Storage: Expanding the capabilities and applications of DNA data storage within living cells.
  • Standardized DNA Screening: Development of automated, low-cost mechanisms for screening suspicious DNA sequences to prevent misuse.
  • Virus Containment Strategies: Perfecting strategies to prevent large-scale environmental contamination from engineered organisms.
  • Ethical Education: Improving the teaching of ethics to young scientists to foster informed decision-making.
  • Strengthening International Collaboration: Continued efforts to build global consensus on ethics, biosafety, and to address grand challenges through international organizations.

Summary updated

Abstract

Synthetic biology aims to redesign and reconstruct living systems for understanding life or for useful real-world applications. In the past two decades, scientists have been able to use engineered living systems to produce many kinds of products from bioplastics to drugs, to construct a minimal bacterium with a fully synthetic genome and to store huge amount of information within a cell. And in 2020, when the COVID-19 pandemic swept across the world, the synthetic biology community became one of the major forces to develop effective diagnostic approaches as well as the drugs and vaccines, to rapidly cope with this great challenge with the state-of-the-art technologies in their hands. In this panel discussion held on 3rd August 2020, eleven pioneering synthetic biologists from six countries across four continents gathered to discuss the development trend, challenges and biosafety issues concerning synthetic biology. <b>George Church</b> Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and MIT, USA <b>Paul Freemont</b> Professor of Structural Biology in the Department of Infectious Disease at Imperial College and a member of the Science Advisory Board of Tierra Biosciences, UK <b>Akihiko Kondo</b> Professor in School of Science, Technology and Innovation, and Department of Chemical Science and Engineering at Kobe University, Japan <b>Christina Smolke</b> Professor of Bioengineering and of Chemical Engineering at Stanford University and CEO of Antheia Inc., USA <b>Xian-En Zhang</b> Professor at the Institute of Biophysics, Chinese Academy of Sciences, China <b>Chenli Liu (Chair)</b> Professor and Director of Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, China <b>Jim Collins</b> Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT, USA <b>Jay Keasling</b> Professor of Chemical Engineering and Bioengineering at the University of California, Berkeley, USA <b>Sang Yup Lee</b> Dean of KAIST Institutes and Distinguished Professor in the Department of Chemical and Biomolecular Engineering at Korea Advanced Institute of Science and Technology (KAIST), South Korea <b>Claudia Vickers</b> Director of the Future Science Platform in Synthetic Biology at Commonwealth Science and Industry Research Organization (CSIRO), Australia <b>Guoping Zhao</b> Professor at the Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, China.
BibTeX
@inproceedings{zhao2020forum,
  author = {Weijie Zhao},
  title = {{A forum on synthetic biology: meet the great challenges with new technology}},
  booktitle = {National},
  year = {2020},
  doi = {10.1093/nsr/nwaa252},
}
Figure